Circulating cytokine profile in anti-neutrophilic cytoplasmatic autoantibody-associated vasculitis: Prediction of outcome?

Mediators of Inflammation

Volumn 13, Issue 4, 2004, Pages 275-283

  Ohlsson, Sophie ^a   Wieslander, Jörgen ^a,b   Segelmark, Mårten ^a  

^a LUND UNIVERSITY   (Sweden)

^b Wieslab AB   (Sweden)

Author keywords

Anti neutrophilic cytoplasmatic autoantibodies; Autoimmunity; Inflammation; Interleukin 10; Interleukin 6; Interleukin 8; Vasculitis

Indexed keywords

AUTOANTIBODY; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; AGED; ARTICLE; BLOOD LEVEL; DISEASE ACTIVITY; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; REMISSION; RISK ASSESSMENT; SYSTEMIC VASCULITIS; VASCULITIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; CHEMOKINE CCL2; COHORT STUDIES; CYTOKINES; FEMALE; HUMANS; INTERLEUKINS; MALE; MIDDLE AGED; MONOCYTES; NEOPTERIN; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; VASCULITIS;

EID: 9644270174     PISSN: 09629351     EISSN: None     Source Type: Journal    
DOI: 10.1080/09629350400003100     Document Type: Article

References (34)

1. Jennette JC, Wilkman AS, Falk RJ. Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis. Am J Pathol 1989; 135: 921-930.
2. Hellmich B, Csernok E, Gross WL, et al. 20 years with ANCA (antineutrophil cytoplasmic autoantibodies): from seromarker to a major pathogenic player in vasculitis. J Leukoc Biol 2003; 74: 1-2.
3. Noronha IL, Kruger C, Andrassy K, Ritz E, Waldherr R. In situ production of TNF-alpha, IL-1 beta and IL-2R in ANCA-positive glomerulonephritis. Kidney Int 1993; 43: 682-692.
4. Cockwell P, Brooks CJ, Adu D, Savage CO. Interleukin-8: A pathogenetic role in antineutrophil cytoplasmic autoantibody-associated glomerulonephritis. Kidney Int 1999; 55: 852-863
5. Rastaldi MP, Ferrario F, Tunesi S, Yang L. D'Amico G. Intraglomerular and interstitial leukocyte infiltration, adhesion molecules, and interleukin-1 alpha expression in 15 cases of antineutrophil cytoplasmic autoantibody- associated renal vasculitis. Am J Kidney Dis 1996; 27: 48-57.
6. Arimura Y, Minoshima S, Kamiya Y, et al. Serum myeloperoxidase and serum cytokines in anti-myeloperoxidase antibody-associated glomerulonephritis. Clin Nephrol 1993; 40: 256-264.
7. Segelmark M, Westman K, Wieslander J. How and why should we detect ANCA? Clin Exp Rheumatol 2000; 18: 629-635.
8. Tervaert JW, van der Woude FJ, Fauci AS, et al. Association between active Wegener's granulomatosis and anticytoplasmic antibodies. Arch Intern Med 1989; 149: 2461-2465.
9. Ralston DR, Marsh CB, Lowe MP, Wewers MD. Antineutrophil cytoplasmic antibodies induce monocyte IL-8 release. Role of surface proteinase-3, alpha 1-antitrypsin, and Fcgamma receptors. J Clin Invest 1997; 100: 1416-1424.
10. Casselman BL, Kilgore KS, Miller BF, Warren JS. Antibodies to neutrophil cytoplasmic antigens induce monocyte chemoattractant protein-1 secretion from human monocytes. J Lab Clin Med 1995; 126: 495-502.
11. Hattar K, Bickenbach A, Csernok E, et al. Wegener's granulomatosis: antiproteinase 3 antibodies induce monocyte cytokine and prostanoid release-role of autocrine cell activation. J Leukoc Biol 2002; 71: 996-1004.
12. Ferrario F, Rastaldi MP. Necrotizing-crescentic glomerulonephritis in ANCA-associated vasculitis: the role of monocytes. Nephrol Dial Transplant 1999; 14: 1627-1631.
13. Muller Kobold AC, Kallenberg CG, Tervaert JW. Monocyte activation in patients with Wegener's granulomatosis. Ann Rheum Dis 1999; 58: 237-245.
14. Ohlsson SL, Ohlsson C, Segelmark K, Wieslander M. IL-6 as a potential marker of disease in ANCA-associated systemic vasculitis. 33rd Annual Meeting & Scientific Exposition of the ASN 2000, 11-16 October, Toronto, Ontario, Canada. Baltimore, MD, USA: JASN.
15. Ohlsson S, Wieslander J, Segelmark M. Increased circulating levels of proteinase 3 in patients with anti-neutrophilic cytoplasmic autoantibodies- associated systemic vasculitis in remission. Clin Exp Immunol 2003; 131: 528-535.
16. Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 2002; 40: 221-226.
17. Wiik A, Rasmussen N, Wieslander J. Methods to detect autoantibodies to neutrophilic granulocytes. Manual Biol Markers Dis 1993; A9: 1-14.
18. Graziani-Bowering GM, Graham JM, Filion LG. A quick, easy and inexpensive method for the isolation of human peripheral blood monocytes. J Immunol Methods 1997; 207: 157-168.
19. Pendergraft WF, Alcorta DA, Segelmark M, et al. ANCA antigens, proteinase 3 and myeloperoxidase, are not expressed in endothelial cells. Kidney Int 2000; 57: 1981-1990.
20. Pecoits-Filho R, Heimburger O, Barany P, et al. Associations between circulating inflammatory markers and residual renal function in CRF patients. Am J Kidney Dis 2003; 41: 1212-1218.
21. Remick DG, Bolgos GR, Siddiqui J, Shin J, Nemzek JA. Six at six: interleukin-6 measured 6 h after the initiation of sepsis predicts mortality over 3 days. Shock 2002; 17: 463-467.
22. Hynninen M, Valtonen M, Vaara M, et al. Plasma interleukin-8, interleukin-10, and E-selectin levels in neutropenic and non-neutropenic bacteremic patients. Eur J Clin Microbiol Infect Dis 1997; 16: 587-591.
23. Lowe PR, Galley HF, Abdel-Fattah A, Webster NR. Influence of interleukin-10 polymorphisms on interleukin-10 expression and survival in critically ill patients. Crit Care Med 2003; 31: 34-38.
24. Berdowska A, Zwirska-Korczala K. Neopterin measurement in clinical diagnosis. J Clin Pharm Ther 2001; 26: 319-329.
25. Diez-Ruiz A, Tilz GP, Zangerle R, Baier-Bitterlich G, Wachter H, Fuchs D. Soluble receptors for tumor necrosis factor in clinical laboratory diagnosis. Eur J Haematol 1995; 54: 1.
26. Wikman A, Fagergren A, Gunnar OJS, Lundahl J, Jacobson SH. Monocyte activation and relationship to anti-proteinase 3 in acute vasculitis. Nephrol Dial Transplant 2003; 18: 1792-1799.
27. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 2000; 148: 209-214.
28. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-809.
29. Gimdt M, Ulrich C, Kaul H, Sester U, Sester M, Kohler H. Uremia-associated immune defect: the IL-10-CRP axis. Kidney Int Suppl 2003; 84: S76-S79.
30. Muller Kobold AC, Kallenberg CG, Tervaert JW. Leucocyte membrane expression of proteinase 3 correlates with disease activity in patients with Wegener's granulomatosis. Br J Rheumatol 1998; 37: 901-907.
31. Popa ER, Stegeman CA, Bos NA, Kallenberg CG, Tervaert JW. Differential B- and T-cell activation in Wegener's granulomatosis. J Allergy Clin Immunol 1999; 103: 885-894.
32. Berger SP, Seelen MA, Hiemstra PS, et al. Proteinase 3, the major autoantigen of Wegener's granulomatosis, enhances IL-8 production by endothelial cells in vitro. J Am Soc Nephrol 1996; 7: 694-701.
33. Murakozy G, Gaede KI, Ruprecht B, et al. Gene polymorphisms of immunoregulatory cytokines and angiotensin-converting enzyme in Wegener's granulomatosis. J Mol Med 2001; 79: 665-670.
34. Zhou Y, Giscombe R, Huang D, Lefvert AK. Novel genetic association of Wegener's granulomatosis with the interleukin 10 gene. J Rheumatol, 2002; 29: 317-320.